Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | PTGS2 | P35354 | 4/20 | 0.41 |
| ▸ | SOAT1 | P35610 | 3/20 | 0.41 |
| ▸ | S100A4 | P26447 | 1/20 | 0.41 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.39 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.39 |
| ▸ | HTR7 | P34969 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | XDH | P47989 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL202456 | 0.94 | SOAT1 (0.43) | PTGS2SOAT1XDH | |
| SCHEMBL199038 | 0.84 | ALDH1A1 (0.43) | ALDH1A1MAPTNPSR1PTGS2SOAT1 | |
| SCHEMBL202457 | 0.78 | SOAT1 (0.42) | PTGS2SOAT1HDAC1HDAC2 | |
| SCHEMBL31038416 | 0.76 | CNR2 (0.45) | ALDH1A1MAPTNPSR1HDAC1HDAC2 | |
| SCHEMBL20456891 | 0.76 | CNR2 (0.45) | ALDH1A1MAPTNPSR1HDAC1HDAC2 | |
| SCHEMBL2687199 | 0.75 | HDAC1 (0.55) | ALDH1A1MAPTNPSR1PTGS2SOAT1 | |
| SCHEMBL202584 | 0.75 | SOAT1 (0.35) | SOAT1 | |
| SCHEMBL200836 | 0.75 | PSMB5 (0.52) | ALDH1A1NPSR1HPGD | |
| SCHEMBL575895 | 0.74 | ALDH1A1 (0.64) | ALDH1A1MAPTNPSR1PTGS2SOAT1 | |
| SCHEMBL4179998 | 0.74 | ALDH1A1 (0.64) | ALDH1A1MAPTNPSR1PTGS2SOAT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10230023-B2 | Color converter | BASF SE (DE) | 2019-03-12 | — | — | US | disclosed |
| EP-2718395-B1 | Novel illumination device comprising a colour converter | BASF SE (DE) | 2018-02-28 | — | — | EP | disclosed |
| US-20160284947-A1 | NOVEL COLOR CONVERTER | BASF SE (DE) | 2016-09-29 | — | — | US | disclosed |
| US-9406848-B2 | Color converter | BASF SE (DE) | 2016-08-02 | — | — | US | disclosed |
| US-20120138125-A1 | FLUORESCENT SOLAR CONVERSION CELLS BASED ON FLUORESCENT TERYLENE DYES | BASF SE (DE) | 2012-06-07 | — | — | US | disclosed |
| US-8088922-B2 | Dibenzorylenetetracarboximides as infrared absorbers | BASF AKTIENGESELLSCHAFT (DE) | 2012-01-03 | — | — | US | disclosed |
| EP-2029573-B1 | DIBENZORYLENETETRACARBOXIMIDES AS INFRARED ABSORBERS | BASF SE (DE) | 2011-10-26 | — | — | EP | disclosed |
| EP-1904497-B1 | SUBSTITUTED RYLENE DERIVATIVES | BASF SE (DE) | 2011-08-17 | — | — | EP | disclosed |
| US-20100048904-A1 | DIBENZORYLENETETRACARBOXIMIDES AS INFRARED ABSORBERS | BASF AKTIENGESELLSCHAFT (DE) | 2010-02-25 | — | — | US | disclosed |
| EP-2029573-A1 | DIBENZORYLENETETRACARBOXIMIDES AS INFRARED ABSORBERS | BASF SE (DE) | 2009-03-04 | — | — | EP | disclosed |
| US-20080245411-A1 | Fluorescent Solar Conversion Cells Based on Fluorescent Terylene Dyes | BASF SE | 2008-10-09 | — | — | US | disclosed |
| EP-1927141-A2 | FLUORESCENT SOLAR CONVERSION CELLS BASED ON FLUORESCENT TERYLENE DYES | BASF SE (DE) | 2008-06-04 | — | — | EP | disclosed |
| EP-1904497-A1 | SUBSTITUTED RYLENE DERIVATIVES | BASF SE (DE) | 2008-04-02 | — | — | EP | disclosed |
| WO-2007138051-A1 | DIBENZORYLENETETRACARBOXIMIDES AS INFRARED ABSORBERS | BASF SE (DE) | 2007-12-06 | — | — | WO | disclosed |
| WO-2007031446-A2 | FLUORESCENT SOLAR CONVERSION CELLS BASED ON FLUORESCENT TERYLENE DYES | BASF SE (DE) | 2007-03-22 | — | — | WO | disclosed |
| WO-2007006717-A1 | SUBSTITUTED RYLENE DERIVATIVES | BASF AKTIENGESELLSCHAFT (DE) | 2007-01-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100048904-A1 | DIBENZORYLENETETRACARBOXIMIDES AS INFRARED ABSORBERS | TDO2, C9, CYP3A43 | ALDH1A1 627/4885MAPT 4364/4885NPSR1 2456/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.